Pevisone treatment of atopic dermatitis clinical observation.docVIP

 PAGE \* MERGEFORMAT 6 Pevisone treatment of atopic dermatitis clinical observation [Keywords:] Pevisone atopic dermatitis Atopic dermatitis (AD, formerly known as atopic dermatitis, is a refractory, chronic, inflammatory skin diseases, the incidence in children around the world for 10% to 20%, adults 1% to 3%, good occur in allergic infants and young physique. Clinically, itching, rash with typical distribution and chronic disease process is characterized by its complex etiology and pathogenesis is unknown, the current lack of an ideal treatment. I Division in June 2003 to June 2005 using Pevisone (Xian-Janssen Pharmaceutical Ltd treatment of AD, with satisfactory results, are as follows. Materials and Methods 1. Case Selection Selection criteria: All patients were diagnosed according to Hanifin-Rajka criteria [1]. Ages 3 to 56 years old, male or female, is willing to cooperate with treatment, participate in the observer. Exclusion criteria: 1 week before the selection of other topical or oral corticosteroids hormone, 1 month, use of antibiotics or antifungal drugs, patients with severe visceral disease, pregnant women, lactating women, drugs or ingredients with known allergy, discontinuation were adverse reactions, not completed treatment or drug users as required. 2. General Information All the cases were hospitalized in our hospital dermatology clinics and patients, according to Hanifin-Rajka diagnostic criteria were diagnosis of AD 72 cases. By randomized treatment group, 36 patients, 20 males, 16 females, aged 3 to 52 years, the average 25.6 years, duration of six months to 15 years, an average of 2 years and 10 months. the control group 36 cases, 21 males and 15 females, aged 3.6 to 56 years, average 26.8 years, duration of 10 months to 16 years, the average of 3 years 1 month. group sex, age, duration and so there was no significant difference (P 0.05, comparable. 3. Treatment Pevisone cream treatment group and control gro